Extracellular Matrix Remodeling by Bone Marrow Fibroblast-like Cells Correlates with Disease Progression in Multiple Myeloma
- 2 December 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 13 (2) , 844-854
Abstract
The pathogenesis of multiple myeloma (MM) is regarded as a multistep process, in which an asymptomatic stage of monoclonal gammopathy of undetermined significance (MGUS) precedes virtually all cases of MM. Molecular events characteristic for the transition from MGUS to MM are still poorly defined. We hypothesized that fibroblast-like cells in the tumor microenvironment are critically involved in the pathogenesis of MM. Therefore, we performed a comparative proteome profiling study, analyzing primary human fibroblast-like cells isolated from the bone marrow of MM, of MGUS, as well as of non-neoplastic control patients. Thereby, a group of extracellular matrix (ECM) proteins, ECM receptors, and ECM-modulating enzymes turned out to be progressively up-regulated in MGUS and MM. These proteins include laminin α4, lysyl-hydroxylase 2, prolyl 4-hydroxylase 1, nidogen-2, integrin α5β5, c-type mannose receptor 2, PAI-1, basigin, and MMP-2, in addition to PDGF-receptor β and the growth factor periostin, which are likewise involved in ECM activities. Our results indicate that ECM remodeling by fibroblast-like cells may take place already at the level of MGUS and may become even more pronounced in MM. The identified proteins which indicate the stepwise progression from MGUS to MM may offer new tools for therapeutic strategies.Keywords
This publication has 54 references indexed in Scilit:
- From Myeloma Precursor Disease to Multiple Myeloma: New Diagnostic Concepts and Opportunities for Early InterventionClinical Cancer Research, 2011
- Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progressionNature Medicine, 2011
- Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: New Insights into Pathophysiology and EpidemiologyHematology-American Society Hematology Education Program, 2010
- The Hemopoietic Stem Cell Niche Versus the Microenvironment of the Multiple Myeloma-Tumor Initiating CellCancer Microenvironment, 2010
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective studyBlood, 2009
- Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progressionBritish Journal of Haematology, 2007
- Bone marrow mesenchymal stem cells are abnormal in multiple myelomaLeukemia, 2007
- The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: Interplay of growth factors, their receptors and stromal interactionsEuropean Journal of Cancer, 2006
- Molecular Pathogenesis and a Consequent Classification of Multiple MyelomaJournal of Clinical Oncology, 2005
- New insights into the pathophysiology of multiple myelomaThe Lancet Oncology, 2003